Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Current Opinion in Pulmonary Medicine
|
October 10, 2003
Noninvasive biomarkers of airway inflammation in cystic fibrosis
Scott D Sagel
Advances in Pediatrics
|
August 30, 2005
Identifying novel endpoints for cystic fibrosis clinical trials
Scott D Sagel
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 11, 2015
The challenges of developing effective anti-inflammatory agents in cystic fibrosis
Scott D Sagel
The Journal of Pediatrics
|
May 27, 2011
Nasal nitric oxide: diagnostic value and physiological significance in primary ciliary dyskinesia
Scott D Sagel
American Journal of Respiratory and Critical Care Medicine
|
March 16, 2019
Shifting Landscape of Airway Infection in Early Cystic Fibrosis
Jordana E Hoppe, Scott D Sagel
Clinical Reviews in Allergy & Immunology
|
August 7, 2002
Monitoring inflammation in CF. Cytokines
Scott D Sagel, Frank J Accurso
Pediatric Pulmonology
|
January 7, 2005
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis
Scott D Sagel, Robert K Kapsner, Iris Osberg
Proceedings of the American Thoracic Society
|
July 27, 2007
Sputum biomarkers of inflammation in cystic fibrosis lung disease
Scott D Sagel, James F Chmiel, Michael W Konstan
Current Opinion in Pediatrics
|
April 16, 2011
The airway microbiome in cystic fibrosis and implications for treatment
Edith T Zemanick, Scott D Sagel, Jonathan K Harris
Pediatric Allergy, Immunology, and Pulmonology
|
January 26, 2012
Primary Ciliary Dyskinesia in Children: A Review for Pediatricians, Allergists, and Pediatric Pulmonologists
Paul C Stillwell, Eric P Wartchow, Scott D Sagel
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Current Opinion in Pulmonary Medicine
|
October 10, 2003
Noninvasive biomarkers of airway inflammation in cystic fibrosis
Scott D Sagel
Advances in Pediatrics
|
August 30, 2005
Identifying novel endpoints for cystic fibrosis clinical trials
Scott D Sagel
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 11, 2015
The challenges of developing effective anti-inflammatory agents in cystic fibrosis
Scott D Sagel
The Journal of Pediatrics
|
May 27, 2011
Nasal nitric oxide: diagnostic value and physiological significance in primary ciliary dyskinesia
Scott D Sagel
American Journal of Respiratory and Critical Care Medicine
|
March 16, 2019
Shifting Landscape of Airway Infection in Early Cystic Fibrosis
Jordana E Hoppe, Scott D Sagel
Clinical Reviews in Allergy & Immunology
|
August 7, 2002
Monitoring inflammation in CF. Cytokines
Scott D Sagel, Frank J Accurso
Pediatric Pulmonology
|
January 7, 2005
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis
Scott D Sagel, Robert K Kapsner, Iris Osberg
Proceedings of the American Thoracic Society
|
July 27, 2007
Sputum biomarkers of inflammation in cystic fibrosis lung disease
Scott D Sagel, James F Chmiel, Michael W Konstan
Current Opinion in Pediatrics
|
April 16, 2011
The airway microbiome in cystic fibrosis and implications for treatment
Edith T Zemanick, Scott D Sagel, Jonathan K Harris
Pediatric Allergy, Immunology, and Pulmonology
|
January 26, 2012
Primary Ciliary Dyskinesia in Children: A Review for Pediatricians, Allergists, and Pediatric Pulmonologists
Paul C Stillwell, Eric P Wartchow, Scott D Sagel
Page
of 14